{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:58:06Z","timestamp":1780052286352,"version":"3.53.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.bcp.2007.05.013","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:23:21Z","timestamp":1180095801000},"page":"639-646","source":"Crossref","is-referenced-by-count":13,"title":["A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of pentoxifylline"],"prefix":"10.1016","volume":"74","author":[{"given":"Jennifer M.","family":"Raoul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa C.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2007.05.013_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"PTX, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2007.05.013_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0190-9622(94)70069-9","article-title":"Pentoxifylline","volume":"30","author":"Samlaska","year":"1994","journal-title":"J Am Acad Deramtol"},{"key":"10.1016\/j.bcp.2007.05.013_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/ajhp\/58.6.485","article-title":"Treatment of intermittent claudication with pentoxifylline and cilostazol","volume":"58","author":"Tjon","year":"2001","journal-title":"Am J Health Sys Pharm"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2007.05.013_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-2478(93)90022-T","article-title":"In vitro immunomodulatory effects of pentoxifylline","volume":"37","author":"Rieneck","year":"1993","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.bcp.2007.05.013_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00007890-199307000-00036","article-title":"Immune response modulation by pentoxifylline in vitro","volume":"56","author":"Tilg","year":"1993","journal-title":"Transplantation"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2007.05.013_bib6","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/00005344-199500252-00017","article-title":"Production of proinflammatory cytokine and cytokines involved in the TH1\/TH2 balance is modulated by pentoxifylline","volume":"25","author":"Bienvenu","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.bcp.2007.05.013_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/08820139509060716","article-title":"Monocyte-mediated regulation of the antigen-driven IFN gamma production by T cells","volume":"24","author":"Mytar","year":"1995","journal-title":"Immunol Invest"},{"issue":"2","key":"10.1016\/j.bcp.2007.05.013_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-5728(95)00176-X","article-title":"Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis","volume":"64","author":"Rieckmann","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.bcp.2007.05.013_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0306-3623(96)00314-X","article-title":"Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis","volume":"29","author":"Windmeier","year":"1997","journal-title":"Gen Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2007.05.013_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.40.4.475","article-title":"In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease","volume":"40","author":"Reimund","year":"1997","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bcp.2007.05.013_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1074-7613(00)80423-9","article-title":"c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation","volume":"6","author":"Wang","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2007.05.013_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bcp.2004.03.035","article-title":"Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction","volume":"68","author":"Peterson","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2007.05.013_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1997.8357","article-title":"Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts","volume":"149","author":"Isbrucker","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2007.05.013_bib14","first-page":"S76","article-title":"Effect of pentoxifylline in collagenous colitis","volume":"10","author":"Peterson","year":"1996","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.bcp.2007.05.013_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0163-7258(94)00072-B","article-title":"Novel insights into the biology and physiology of the Ito cell","volume":"66","author":"Pinzani","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2007.05.013_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.510260210","article-title":"Pentoxifylline inhibits growth and collagen synthesis of cultured human myofibroblasts-like cells","volume":"26","author":"Preaux","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2007.05.013_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/jmcc.1998.0910","article-title":"Pentoxifylline inhibits PDGF-induced proliferation and TGF-\u03b2-stimulated collagen synthesis by vascular smooth muscle cells","volume":"31","author":"Chen","year":"1999","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.bcp.2007.05.013_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000013562","article-title":"Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion","volume":"20","author":"Hewitson","year":"2000","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1016\/j.bcp.2007.05.013_bib19","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1097\/01.ASN.0000034909.10994.8A","article-title":"Pentoxifylline attenuated the renal disease progression in rats with remnant kidney","volume":"13","author":"Lin","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.bcp.2007.05.013_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bcp.2007.05.013_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hep.1840150205","article-title":"Fibroproliferation in liver disease: role of monocyte factors","volume":"15","author":"Peterson","year":"1992","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2007.05.013_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840170320","article-title":"Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts","volume":"17","author":"Peterson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2007.05.013_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0162-3109(95)00048-8","article-title":"Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism","volume":"31","author":"Peterson","year":"1996","journal-title":"Immunopharmacol"},{"key":"10.1016\/j.bcp.2007.05.013_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jps.2600750111","article-title":"Pharmacokinetics of orally administered pentoxifylline in humans","volume":"75","author":"Smith","year":"1986","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2007.05.013_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/000331978403500703","article-title":"Pharmacology of PTX: a hemorrheologic agent for the treatment of intermittent claudication","volume":"35","author":"Aviado","year":"1984","journal-title":"Angiol"},{"issue":"11","key":"10.1016\/j.bcp.2007.05.013_bib26","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/IAI.60.11.4504-4509.1992","article-title":"Effect of ingested pentoxifylline on neutrophil superoxide production","volume":"60","author":"Crouch","year":"1992","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.bcp.2007.05.013_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0006-2952(96)00311-5","article-title":"Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors","volume":"52","author":"Peterson","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2007.05.013_bib28","first-page":"4","article-title":"Effect of PDGF, PTX and M-1 on collagen synthesis in porcine hepatic stellate cells","volume":"22","author":"Isbrucker","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2007.05.013_bib29","first-page":"3436","article-title":"Phase 1b trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal carcinoma","volume":"54","author":"Thompson","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2007.05.013_bib30","first-page":"453A","article-title":"Investigation of the PTX\/CIPRO drug interaction in the mouse","volume":"26","author":"Wornell","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2007.05.013_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0162-3109(94)90061-2","article-title":"In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists","volume":"28","author":"Peterson","year":"1994","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bcp.2007.05.013_bib32","series-title":"Organic Chemistry: structure and reactivity","first-page":"196","article-title":"Stereochemistry","author":"Ege","year":"1994"},{"key":"10.1016\/j.bcp.2007.05.013_bib33","first-page":"4","article-title":"Effect of PTX in a heterologous serum model of fibrosis","volume":"22","author":"Hodgson","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2007.05.013_bib34","first-page":"558A","article-title":"Increased level of antifibrotic drugs due to selective inhibition of CYP1A2","volume":"30","author":"Blanchard","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2007.05.013_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/chir.10121","article-title":"Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans","volume":"14","author":"Nicklasson","year":"2002","journal-title":"Chirality"},{"issue":"11","key":"10.1016\/j.bcp.2007.05.013_bib36","first-page":"174","article-title":"Metabolism of lysofylline and pentoxifylline in human liver microsomes and cytosol","volume":"24","author":"Lillibridge","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.bcp.2007.05.013_bib37","first-page":"1354","article-title":"Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver mocrosomes","volume":"25","author":"Lee","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2007.05.013_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/AAC.36.5.942","article-title":"Inhibitory potency of quinolone antibacterial agents against cytochrome P4501A2 activity in vivo and in vitro","volume":"36","author":"Fuhr","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2007.05.013_bib39","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(00)03409-7","article-title":"Methadone, ciprofloxacin and adverse drug reactions","volume":"356","author":"Herrlin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2007.05.013_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0162-3109(98)00021-6","article-title":"The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP","volume":"39","author":"Peterson","year":"1998","journal-title":"Imunopharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2007.05.013_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/js970382f","article-title":"CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes","volume":"87","author":"Shin","year":"1998","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.bcp.2007.05.013_bib42","first-page":"1134","article-title":"Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human","volume":"24","author":"McLellan","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.bcp.2007.05.013_bib43","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"10.1016\/j.bcp.2007.05.013_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520700322X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520700322X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:49:07Z","timestamp":1737049747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629520700322X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S000629520700322X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2007.05.013","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}